Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 5651-5700 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05834738
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy
PHASE2
Active, not recruiting
54 participants
Started: Jul 20, 2023 · Completed: Aug 19, 2026
2 conditions
1 sponsor
30 locations
NCT05825781
Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man
PHASE1
Active, not recruiting
114 participants
Started: Jul 20, 2023 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT06711484
Evaluation of the Efficiency of a Training Program Developed For Newly Graduate Nurses
NA
Active, not recruiting
76 participants
Started: Jul 20, 2023 · Completed: Jun 24, 2025
3 conditions
1 sponsor
1 location
NCT05936151
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
PHASE2
Active, not recruiting
146 participants
Started: Jul 20, 2023 · Completed: Nov 30, 2025
3 conditions
1 sponsor
42 locations
NCT06138769
Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma
PHASE2
Active, not recruiting
50 participants
Started: Jul 20, 2023 · Completed: Nov 1, 2027
1 condition
21 sponsors
1 location
NCT05889052
Perennial Malaria Chemoprevention (PMC) in Cameroon
N/A
Active, not recruiting
2,080 participants
Started: Jul 19, 2023 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT07096206
Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study
N/A
Active, not recruiting
27 participants
Started: Jul 19, 2023 · Completed: Nov 19, 2026
1 condition
1 sponsor
2 locations
NCT05880706
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
198 participants
Started: Jul 19, 2023 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05864573
Study of ZGGS15 in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
22 participants
Started: Jul 19, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06279702
Serious Game Simulation and Comics in School Students
NA
Active, not recruiting
54 participants
Started: Jul 19, 2023 · Completed: Jul 19, 2025
1 condition
1 sponsor
1 location
NCT05933577
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
PHASE3
Active, not recruiting
1,089 participants
Started: Jul 19, 2023 · Completed: Sep 26, 2030
1 condition
2 sponsors
165 locations
NCT05628350
Highly Processed Foods and Vascular Health
NA
Active, not recruiting
17 participants
Started: Jul 19, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05924464
Group Preconception Care for Fertility Patients
NA
Active, not recruiting
140 participants
Started: Jul 19, 2023 · Completed: Jun 30, 2027
1 condition
3 sponsors
1 location
NCT05959512
Smoking Pattern and Influencing Factors in Hospitalized Patients
N/A
Active, not recruiting
200 participants
Started: Jul 19, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05783596
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
PHASE2
Active, not recruiting
47 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2029
3 conditions
2 sponsors
4 locations
NCT05852691
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
PHASE2
Active, not recruiting
83 participants
Started: Jul 18, 2023 · Completed: Dec 18, 2026
1 condition
1 sponsor
38 locations
NCT05801029
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
PHASE2
Active, not recruiting
60 participants
Started: Jul 18, 2023 · Completed: Oct 1, 2027
1 condition
2 sponsors
29 locations
NCT05964205
Analysis of a Stepped-Wedge Implementation of the PT-PENCIL Tool
N/A
Active, not recruiting
9,704 participants
Started: Jul 18, 2023 · Completed: Oct 30, 2025
1 condition
2 sponsors
1 location
NCT06968585
A Study of A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy
PHASE3
Active, not recruiting
365 participants
Started: Jul 18, 2023 · Completed: Mar 31, 2028
1 condition
1 sponsor
1 location
NCT05917860
Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer
PHASE1
Active, not recruiting
15 participants
Started: Jul 18, 2023 · Completed: Jan 31, 2030
4 conditions
1 sponsor
1 location
NCT05773365
PENG Block Plus Local Infiltration Compared to PENG Block Alone in Hip Surgery
NA
Active, not recruiting
122 participants
Started: Jul 18, 2023 · Completed: Jul 1, 2025
4 conditions
1 sponsor
1 location
NCT05567016
CHILD (Child Health and Infection With Low Density) Malaria
NA
Active, not recruiting
600 participants
Started: Jul 18, 2023 · Completed: Nov 28, 2025
2 conditions
6 sponsors
1 location
NCT05733143
Using Exercise-testing to Explore Patient Differences in Severe Asthma
N/A
Active, not recruiting
64 participants
Started: Jul 18, 2023 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05937074
Metabolic Response to Food in Lung Cancer
N/A
Active, not recruiting
5 participants
Started: Jul 18, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06429566
Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous Ulcers
PHASE2
Active, not recruiting
120 participants
Started: Jul 18, 2023 · Completed: Jul 10, 2026
1 condition
1 sponsor
1 location
NCT05973331
Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
N/A
Active, not recruiting
6,134,060 participants
Started: Jul 17, 2023 · Completed: Sep 30, 2026
2 conditions
3 sponsors
1 location
NCT05985070
Evaluating the Effectiveness of Various Iron Salts in Oral Iron Therapy for Iron Deficiency and Anemia in Healthy Adults
NA
Active, not recruiting
59 participants
Started: Jul 17, 2023 · Completed: Jun 30, 2025
2 conditions
1 sponsor
3 locations
NCT05756634
Health and Wellness After Preterm Birth
NA
Active, not recruiting
67 participants
Started: Jul 17, 2023 · Completed: Oct 9, 2025
6 conditions
3 sponsors
1 location
NCT05806138
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
PHASE2
Active, not recruiting
21 participants
Started: Jul 17, 2023 · Completed: Jul 17, 2028
2 conditions
2 sponsors
1 location
NCT06128863
Pembrolizumab in Combination with Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients with Soft Tissue Sarcoma - EFTISARC-NEO Trial
PHASE2
Active, not recruiting
40 participants
Started: Jul 17, 2023 · Completed: Apr 30, 2027
4 conditions
2 sponsors
1 location
NCT06059300
Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening Program
NA
Active, not recruiting
18,200 participants
Started: Jul 17, 2023 · Completed: Jul 1, 2028
1 condition
13 sponsors
1 location
NCT05554601
A Randomized Trial of Behaviorally Designed Gamification and Social Incentives to Increase Physical Activity Among Overweight and Obese Veterans
NA
Active, not recruiting
725 participants
Started: Jul 17, 2023 · Completed: Jul 1, 2026
2 conditions
1 sponsor
1 location
NCT05518162
Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App
NA
Active, not recruiting
152 participants
Started: Jul 17, 2023 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT05776719
Efficacy of Virtual Warrior Renew Therapy for Veterans Who Experienced Military Sexual Trauma
NA
Active, not recruiting
191 participants
Started: Jul 17, 2023 · Completed: Oct 30, 2026
2 conditions
2 sponsors
2 locations
NCT05180045
Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure
NA
Active, not recruiting
472 participants
Started: Jul 17, 2023 · Completed: Jun 30, 2026
2 conditions
2 sponsors
20 locations
NCT06621446
The Beijing Adult Dry Eye Cohort Study
N/A
Active, not recruiting
1,200 participants
Started: Jul 15, 2023 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05905133
A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
PHASE2
Active, not recruiting
360 participants
Started: Jul 15, 2023 · Completed: Jun 30, 2024
1 condition
1 sponsor
38 locations
NCT05259943
Microdosing Psychedelics to Improve Mood
PHASE2
Active, not recruiting
50 participants
Started: Jul 15, 2023 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT05540132
Slow Digestible Carbohydrates and Exercise in Adolescents with Type 1 Diabetes
NA
Active, not recruiting
20 participants
Started: Jul 15, 2023 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT05680727
Individualized Functional Connectivity Targeting in aiTBS for Depression
PHASE2
Active, not recruiting
40 participants
Started: Jul 15, 2023 · Completed: Mar 17, 2027
5 conditions
1 sponsor
1 location
NCT05929482
Impact of a Telenovela/Soap Opera for HIV Prevention in Latinas
NA
Active, not recruiting
142 participants
Started: Jul 15, 2023 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT07085936
Stress and Stigma Among Psychiatric Caregivers: Effects of a Video-Based Orientation and Feature Importance Via SVR
NA
Active, not recruiting
60 participants
Started: Jul 15, 2023 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05314647
Lutein Supplementation in Healthy Children
NA
Active, not recruiting
59 participants
Started: Jul 15, 2023 · Completed: May 31, 2024
3 conditions
1 sponsor
1 location
NCT05944432
CGM Use in Adults With Type 2 Diabetes on Basal Insulin
NA
Active, not recruiting
470 participants
Started: Jul 14, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
25 locations
NCT05900986
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
PHASE1/PHASE2
Active, not recruiting
100 participants
Started: Jul 14, 2023 · Completed: May 31, 2026
3 conditions
1 sponsor
9 locations
NCT05968430
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
PHASE3
Active, not recruiting
1,400 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
175 locations
NCT06612021
Hema Free Versus Hema Containing Adhesives in Posterior Restorations
NA
Active, not recruiting
64 participants
Started: Jul 14, 2023 · Completed: Nov 1, 2024
1 condition
1 sponsor
1 location
NCT05554341
Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial
PHASE2
Active, not recruiting
40 participants
Started: Jul 14, 2023 · Completed: Jun 30, 2026
2 conditions
1 sponsor
126 locations
NCT05943795
A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
PHASE3
Active, not recruiting
589 participants
Started: Jul 14, 2023 · Completed: Jul 31, 2026
2 conditions
1 sponsor
2 locations
NCT05616949
Peer Recovery Support Services for Individuals in Recovery Residences on MOUD
NA
Active, not recruiting
50 participants
Started: Jul 14, 2023 · Completed: Sep 29, 2025
2 conditions
3 sponsors
2 locations
Previous
1
More pages
111
112
113
114
115
116
117
More pages
431
Next